1. Home
  2. VIPS vs LGND Comparison

VIPS vs LGND Comparison

Compare VIPS & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vipshop Holdings Limited

VIPS

Vipshop Holdings Limited

N/A

Current Price

$13.86

Market Cap

6.1B

ML Signal

N/A

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

N/A

Current Price

$306.57

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIPS
LGND
Founded
2008
1987
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.0B
IPO Year
2012
1997

Fundamental Metrics

Financial Performance
Metric
VIPS
LGND
Price
$13.86
$306.57
Analyst Decision
Buy
Strong Buy
Analyst Count
21
11
Target Price
$16.08
★ $350.92
AVG Volume (30 Days)
★ 2.1M
198.1K
Earning Date
11-19-2026
10-29-2026
Dividend Yield
★ 4.44%
N/A
EPS Growth
N/A
★ 2886.36
EPS
N/A
★ 0.31
Revenue
N/A
★ $141,102,000.00
Revenue This Year
N/A
$8.68
Revenue Next Year
$0.62
$30.77
P/E Ratio
★ $9.00
$1,019.77
Revenue Growth
N/A
★ 29.48
52 Week Low
$12.02
$175.89
52 Week High
$20.49
$326.63

Technical Indicators

Market Signals
Indicator
VIPS
LGND
Relative Strength Index (RSI) 65.72 50.10
Support Level $13.53 $277.97
Resistance Level $14.14 $318.30
Average True Range (ATR) 0.36 12.09
MACD 0.15 -1.03
Stochastic Oscillator 86.65 30.44

Price Performance

Historical Comparison
VIPS
LGND

About VIPS Vipshop Holdings Limited

Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts of 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurement, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners. As of March 31, 2025, Eric Ya Shen, chair and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds a 12.5% interest.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: